These outcomes, along with a prior report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 aid the strategy of concentrating on ACKR3 as a unique approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Conditions. January three, 2024 Donating https://lucianou285svw4.blogdal.com/profile